In this MASCC 2025 Conference episode, Dr. Christina Ruhlmann, a clinical oncologist from Denmark specializing in supportive care, shares key insights from her talk on emerging toxicities linked to ADCs, TKIs, and ICIs. Focusing on gastrointestinal toxicities such as diarrhea, colitis, nausea, and vomiting, Dr. Ruhlmann explains how understanding the differences in pathogenetic mechanisms is essential for selecting the right management approach for each drug class. She emphasizes the importance of equipping physicians and nurses with this knowledge to better manage these sometimes severe side effects.
